[Non-dopaminergic drugs in schizophrenia].
Llorca
P M
PM
Service de Psychiatrie B, Centre Médico Psychologique, Groupe Hospitalier Saint-Jacques, 30, place Henri Dunant, BP 69, 63003 Clermont-Ferrand cedex.
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D000077213:Lamotrigine; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000235:genetics; D011954:Receptors, Dopamine / Q000187:drug effects / Q000235:genetics; D018079:Receptors, GABA / Q000187:drug effects / Q000235:genetics; D018009:Receptors, Glycine / Q000187:drug effects / Q000235:genetics; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000235:genetics; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D012565:Schizophrenic Psychology; D014227:Triazines / Q000627:therapeutic use
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D011619:Psychotropic Drugs; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D018079:Receptors, GABA; D018009:Receptors, Glycine; D016194:Receptors, N-Methyl-D-Aspartate; D014227:Triazines; D000077213:Lamotrigine